Cross Country Healthcare discloses CEO Kevin Clark's employment terms: $950K salary, bonus, equity

CROSS COUNTRY HEALTHCARE INC

Base salary $950K; 2026 target bonus 100% of base (max 180%), rising to 125% target from 2027.
Long-term equity: 275% of base for 2025, 300% for 2026, 325% for 2027 and 2028.
Severance on termination without cause/good reason: 24 months base salary plus 2x average bonus, plus COBRA.
Initial 3-year term through Dec 14, 2028, with automatic one-year renewals unless 90-day non-renewal notice.
Non-compete and non-solicitation covenants apply for 2 years post-employment.

item 5.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-26-000149
form_type: 8-K/A
ticker: CCRN
cik: 0001141103
company_name: CROSS COUNTRY HEALTHCARE INC
filed_at: 2026-01-02T23:59:59+00:00
discovered_at: 2026-05-14T18:02:34.611529+00:00
generated_at: 2026-05-16T11:46:56.180639+00:00
sec_items: ["5.02", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-26-000149
json_url: https://secwatch.observer/filing/0001628280-26-000149.json
markdown_url: https://secwatch.observer/filing/0001628280-26-000149.md
text_url: https://secwatch.observer/filing/0001628280-26-000149.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1141103/000162828026000149/0001628280-26-000149-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1141103/000162828026000149/ccrn-20251215.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001628280-26-000149

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.